# Clinico Microbiological Profile of Diabetic Foot Ulcers: A Retrospective Study

**Authors:** Liza Das, Shradha Smriti, Rajesh K Dash, Nipa Singh, Subhra Snigdha Panda, Ipsa Mohapatra, Niranjan Moharana, Bansidhar Mulia, Sambit Das, Dipti Pattnaik

PMC · DOI: 10.7759/cureus.95291 · Cureus · 2025-10-24

## TL;DR

This study analyzed the bacteria and fungi causing infections in diabetic foot ulcers and their response to antibiotics to guide better treatment.

## Contribution

The study provides a detailed microbiological and antibiotic susceptibility profile of pathogens in diabetic foot ulcers from a specific hospital setting.

## Key findings

- Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, and Enterococcus spp. were the most common bacterial isolates.
- Carbapenems like imipenem and meropenem were most effective against Pseudomonas aeruginosa.
- MRSA was prevalent among Staphylococcus aureus isolates, with high sensitivity to vancomycin and teicoplanin.

## Abstract

Introduction and aim: Diabetic foot ulcer (DFU) is a frequent and critical complication associated with diabetes mellitus. They carry a higher risk of infection, longer hospital stays, and increased healthcare costs. This study aimed to identify the microbiological profile and antibiotic susceptibility pattern of organisms isolated from infected diabetic foot ulcers.

Material and methods: A retrospective, record-based, cross-sectional study was conducted by retrieving data on culture isolates obtained from diabetic foot ulcers and the clinical data of these patients over a period of two years (from August 2022 to August 2024) at a tertiary care hospital. The demographic, clinical, and laboratory data were retrieved from the laboratory information system; all data were entered into an Excel spreadsheet (Redmond, WA: Microsoft Corp.), and the variables were analyzed.

Results: A total of 100 patients with DFUs, and the details of 156 samples obtained from the diabetic foot ulcers of these patients, were included in the study. Among the 100 patients, the majority were male (76%, 76/100), and the age group most commonly affected was 50-60 years (40%, 40/100). Pus was the predominant sample (41.7%, 65/156) among the total 156 samples collected. Among the 156 samples collected, 62.2% (97/156) showed mono-microbial growth, and 37.8% (59/156) showed poly-microbial growth. The total number of bacterial and fungal isolates was 213 and five, respectively. All fungal isolates were identified to be Candida tropicalis. The most common bacterial isolates were Pseudomonas aeruginosa (18.8%, 40/213), Klebsiella pneumoniae (17.8%, 38/213), Escherichia coli (14.1%, 30/213), and Enterococcus spp. (12.7%, 27/213), and Staphylococcus aureus (11.7%, 25/213). The most effective antibiotics for Pseudomonas aeruginosa were carbapenems, imipenem (90%, 36/40) and meropenem (80%, 32/40), followed by piperacillin-tazobactam (75%, 30/40) and amikacin (75%, 30/40). Imipenem (55%, 21/38) was the most sensitive antibiotic for Klebsiella pneumoniae followed by gentamicin (45%, 17/38). For Gram-positive isolates, Enterococcus spp. was most sensitive to teicoplanin and linezolid (100%, 27/27), followed by ampicillin (96.3%, 26/27) and vancomycin (77.8%, 21/27). Staphylococcus aureus isolates were most sensitive to vancomycin and teicoplanin (92%, 23/25), followed by daptomycin (84%, 21/25). A total of 25 Staphylococcus aureus isolates were obtained, of which 92% (23/25) were found to be methicillin-resistant Staphylococcus aureus (MRSA).

Conclusion: This study has enhanced our understanding of the epidemiology of diabetic foot ulcers by identifying common pathogens. The antibiotic susceptibility pattern of the pathogens will help clinicians provide better empirical therapy, thereby promoting faster wound healing.

## Linked entities

- **Diseases:** diabetes mellitus (MONDO:0005015)
- **Species:** Pseudomonas aeruginosa (taxon 287), Klebsiella pneumoniae (taxon 573), Escherichia coli (taxon 562), Staphylococcus aureus (taxon 1280), Candida tropicalis (taxon 5482)

## Full-text entities

- **Diseases:** infected (MESH:D007239), DFU (MESH:D017719), fungal (MESH:D009181), bacterial (MESH:D001424), diabetes mellitus (MESH:D003920)
- **Chemicals:** ampicillin (MESH:D000667), carbapenems (MESH:D015780), teicoplanin (MESH:D017334), linezolid (MESH:D000069349), vancomycin (MESH:D014640), daptomycin (MESH:D017576), piperacillin-tazobactam (MESH:D000077725), gentamicin (MESH:D005839), amikacin (MESH:D000583), Imipenem (MESH:D015378), meropenem (MESH:D000077731)
- **Species:** Klebsiella pneumoniae (species) [taxon 573], Pseudomonas aeruginosa (species) [taxon 287], Staphylococcus aureus (species) [taxon 1280], Escherichia coli (E. coli, species) [taxon 562], Homo sapiens (human, species) [taxon 9606], Candida tropicalis (species) [taxon 5482]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12640533/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12640533/full.md

## References

51 references — full list in the complete paper: https://tomesphere.com/paper/PMC12640533/full.md

---
Source: https://tomesphere.com/paper/PMC12640533